Carmignac Gestion’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
Other funds holding APGE
Carmignac Gestion's APGE Position: Q3 2026 in Review
Carmignac Gestion sold out of Apogee Therapeutics (APGE) in Q3 2026, closing a stake of 44,475 shares — an estimated $5.9M sold.
Carmignac Gestion first reported a position in APGE in Q2 2026 and held it in 1 quarter. The position peaked at $5.9M in Q2 2026. 2 funds tracked by Wall St. Rank hold APGE as of Q3 2026.
- Carmignac Gestion reported no remaining Apogee Therapeutics position as of Q3 2026 after selling out during the quarter.
- Carmignac Gestion sold 44,475 Apogee Therapeutics shares in Q3 2026, an estimated $5.9M.
- Carmignac Gestion first reported a position in Apogee Therapeutics in Q2 2026 and held it in 1 quarter.
- Carmignac Gestion's Apogee Therapeutics position peaked at $5.9M in Q2 2026.
- 2 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q3 2026.
Based on Carmignac Gestion's 13F filing for Q3 2026, filed 13 Nov 2026.